V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008957 | 280006184 | 1.75 | 56.7 | Adjuvant (A) | 2013-10-13 | 2013-12-18 | PACLITAXEL + TRASTUZUMAB | N | N | 280029448 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280008958 | 280009240 | 1.68 | 92 | Palliative (P) | 2017-12-19 | 2018-01-09 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 280029450 | IRINOTECAN + VINCRISTINE |
| 280008959 | 280009240 | 0 | 61 | Curative (C) | 2014-03-27 | 2014-03-28 | Capecitabine (14 days)+Carboplatin | 02 | Y | 280029450 | PAZOPANIB |
| 280008960 | 280006188 | null | 64.2 | Curative (C) | 2018-05-01 | 2018-05-01 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029459 | VIDE |
| 280008961 | 280006190 | 1.7 | null | null | 2016-08-07 | 2016-08-16 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 280029460 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280008962 | 280010707 | 1.61 | null | Curative (C) | 2015-05-03 | 2015-05-07 | Panitumumab | N | null | 280029462 | DARS TRIAL |
| 280008963 | 280006191 | 1.79 | 83.95 | Palliative (P) | 2016-05-08 | 2017-01-15 | Capecitabine + Streptozocin | N | null | 280029464 | CVD |
| 280008964 | 280006192 | 1.75 | 104 | Curative (C) | 2015-10-26 | 2015-12-22 | CAPECITABINE + IRINOTECAN | N | N | 280029467 | CISPLATIN + FLUOROURACIL + RT |
| 280008965 | 280006193 | 1.75 | 83.95 | Curative (C) | 2016-02-15 | 2016-02-25 | PEMBROLIZUMAB | N | N | 280029471 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280008966 | 280009243 | 1.72 | 75.6 | Curative (C) | 2014-06-10 | 2014-06-10 | Vincristine (weekly) | null | N | 280029471 | MELPHALAN |
| 280008967 | 280006197 | 1.83 | 77.3 | Curative (C) | 2018-02-22 | 2018-02-23 | CETUXIMAB + IRINOTECAN + MDG | N | N | 280029474 | RITUXIMAB |
| 280008968 | 280006197 | 1.65 | 68.9 | Curative (C) | 2018-12-02 | 2018-12-20 | ABVD | 02 | N | 280029474 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280008969 | 280006198 | null | 91.6 | Curative (C) | 2015-04-03 | 2015-05-09 | BUSULFAN + MELPHALAN | 2 | null | 280029476 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 280008970 | 280006200 | null | 80 | Curative (C) | 2014-12-12 | 2014-12-19 | Carboplatin + Vinorelbine IV | 2 | N | 280029480 | IFOSFAMIDE + VINCRISTINE |
| 280008971 | 280006201 | 0.62 | 93.6 | Neo-adjuvant (N) | 2018-02-18 | 2018-02-26 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 280029484 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 280008972 | 280006201 | 1.61 | 52.3 | Palliative (P) | 2018-03-31 | 2018-04-15 | EOX | null | null | 280029484 | ECX |
| 280008973 | 280010710 | null | 99.9 | null | null | 2017-04-21 | Cisplatin + Pemetrexed | N | N | 280029488 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280008974 | 280006202 | null | null | null | 2014-05-18 | 2014-05-22 | ABVD | N | N | 280029493 | CHOP R |
| 280008975 | 280006203 | 1.72 | 54.1 | Neo-adjuvant (N) | 2015-08-19 | 2015-09-02 | VIDE | 02 | N | 280029494 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280008976 | 280006203 | 1.6 | 42.3 | Neo-adjuvant (N) | 2012-10-30 | 2013-08-27 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029494 | CISPLATIN + FLUOROURACIL + RT |
| 280008977 | 280006204 | 1.59 | 74.7 | Not known (9) | null | 2018-04-22 | R GCVP | N | N | 280029509 | RITUXIMAB |
| 280008978 | 280010712 | 1.76 | 90 | Curative (C) | 2013-06-13 | 2013-07-26 | VINCRISTINE | N | N | 280029512 | IMATINIB |
| 280008979 | 280006206 | null | 85.1 | Adjuvant (A) | 2018-03-07 | 2018-03-10 | BEP 5 Day | null | null | 280029522 | CISPLATIN + FLUOROURACIL + RT |
| 280008980 | 280006206 | 1.81 | 69.3 | Curative (C) | null | 2015-09-17 | Dactinomycin + Vincristine | N | N | 280029522 | IVADO |
| 280008981 | 280006207 | 1.76 | 100 | Palliative (P) | null | 2018-02-22 | CISPLATIN + FLUOROURACIL + RT | N | N | 280029525 | NIVOLUMAB |
| 280008982 | 280006208 | 1.75 | 85 | Curative (C) | 2016-07-02 | 2016-07-03 | VIDE | N | N | 280029531 | CISPLATIN + DOXORUBICIN |
| 280008983 | 280009250 | 1.63 | null | Neo-adjuvant (N) | 2016-06-23 | 2016-07-20 | VIA (Ifos 1.5g/m2) | 2 | N | 280029535 | METHOTREXATE HIGH DOSE |
| 280008984 | 280011768 | 1.71 | 85.1 | Neo-adjuvant (N) | 2013-06-21 | 2013-06-21 | CAPECITABINE + LOMUSTINE | N | N | 280029539 | VIDE |
| 280008985 | 280012029 | 1.63 | 89.2 | Palliative (P) | 2014-08-15 | 2014-08-19 | Panitumumab | 2 | N | 280029539 | IFOSFAMIDE + VINCRISTINE |
| 280008986 | 280012029 | 1.72 | null | Palliative (P) | 2017-12-01 | 2017-12-22 | NIVOLUMAB | N | N | 280029539 | NIVOLUMAB |
| 280008987 | 280012029 | null | null | Curative (C) | null | 2015-01-25 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029539 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280008988 | 280006210 | null | null | Curative (C) | 2017-08-07 | 2017-08-09 | IPILIMUMAB + NIVOLUMAB | null | null | 280029549 | VINCRISTINE |
| 280008989 | 280006210 | 1.63 | 80.5 | null | 2015-06-23 | 2015-06-23 | BCG Intravesical | 02 | null | 280029549 | CARBO + FLUOROURACIL |
| 280008990 | 280006211 | 1.7 | 86.3 | null | 2017-05-18 | 2017-05-23 | LANREOTIDE | Y | N | 280029556 | BENDAMUSTINE + RITUXIMAB |
| 280008991 | 280006214 | 1.67 | 52 | Not known (9) | 2016-09-10 | 2017-09-16 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280029556 | VINORELBINE |
| 280008992 | 280006215 | 1.6 | 99.9 | Curative (C) | null | 2014-02-06 | IVADo | N | N | 280029560 | BUSULFAN + MELPHALAN |
| 280008993 | 280006219 | 1.74 | 83.8 | null | 2015-08-22 | 2015-09-10 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029560 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280008994 | 280006220 | 1.83 | 74 | null | 2015-09-29 | 2015-10-01 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 280029567 | SUNITINIB |
| 280008995 | 280006221 | 1.83 | 79.4 | Palliative (P) | 2016-07-28 | 2016-08-02 | NIVOLUMAB | N | N | 280029571 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280008996 | 280010715 | 1.76 | 76.3 | null | 2018-02-13 | 2018-02-13 | BCG Intravesical | 02 | N | 280029571 | ECX |
| 280008997 | 280006222 | 1.67 | 52.3 | Curative (C) | 2016-01-10 | 2016-01-19 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029576 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280008998 | 280006222 | 0 | 52.3 | Palliative (P) | 2016-07-24 | 2016-07-24 | PACLITAXEL + TRASTUZUMAB | N | N | 280029576 | VINCRISTINE |
| 280008999 | 280010716 | 1.8 | 89.8 | Palliative (P) | 2015-11-26 | 2015-11-29 | Cetuximab+Irinotecan (Cyc2 onwards) | N | null | 280029580 | DOXORUBICIN + HD MTX |
| 280009000 | 280010716 | 1.53 | 74.4 | Disease modification (D) | 2018-03-29 | 2018-03-29 | Capecitabine + Streptozocin | N | N | 280029580 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009001 | 280011769 | 1.59 | 42.3 | Palliative (P) | 2016-04-17 | 2016-04-20 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280029584 | IVADO |
| 280009002 | 280006224 | 1.66 | 77 | Palliative (P) | 2015-01-13 | 2015-01-23 | CARBOPLATIN + FLUOROURACIL | N | N | 280029589 | CISPLATIN + FLUOROURACIL + RT |
| 280009003 | 280009258 | 1.63 | null | Neo-adjuvant (N) | 2016-08-16 | 2016-12-24 | CAPECITABINE + IRINOTECAN | N | N | 280029589 | MITOMYCIN INTRAVESICULAR |
| 280009004 | 280006225 | 0.77 | 61.1 | Palliative (P) | 2015-07-13 | 2015-07-18 | BEP 5 Day | N | N | 280029599 | CARBOPLATIN + VINORELBINE |
| 280009005 | 280006227 | 1.87 | 69.5 | Palliative (P) | 2016-08-20 | 2016-08-20 | Bevacizumab + Irinotecan + MdG | 01 | N | 280029599 | CISPLATIN + FLUOROURACIL + RT |
| 280009006 | 280006227 | 1.69 | 47 | Palliative (P) | null | 2013-06-04 | Cyclophosphamide + Vincristine | Y | N | 280029599 | NIVOLUMAB |